We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-4.76%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$1.85B
AUM Growth
-$19.7M
Cap. Flow
+$132M
Cap. Flow %
7.14%
Top 10 Hldgs %
47.07%
Holding
109
New
9
Increased
32
Reduced
9
Closed
22

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$72.1M
2
CMG icon
Chipotle Mexican Grill
CMG
+$39.8M
3
AMZN icon
Amazon
AMZN
+$39.1M
4
AMD icon
Advanced Micro Devices
AMD
+$35.4M
5
RPRX icon
Royalty Pharma
RPRX
+$31.1M

Top Sells

Rank Stock Value
1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$67.2M
2
XYZ
Block Inc
XYZ
+$28.8M
3
TSM icon
TSMC
TSM
+$23.9M
4
ACN icon
Accenture
ACN
+$21.6M
5
CP icon
Canadian Pacific Kansas City
CP
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 62.92%
2 Consumer Discretionary 12.25%
3 Technology 11.13%
4 Communication Services 4.55%
5 Industrials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
26
DELISTED
KalVista Pharmaceuticals
KALV
$23.3M 1.26%
2,420,851
+386,345
+19% +$3.95M
RH icon
27
RH
RH
$3.71B
$21.4M 1.16%
80,989
-2,200
-3% -$765K
LLY icon
28
Eli Lilly
LLY
$1.06T
$21M 1.13%
+39,100
New +$20.1M
STRO icon
29
Sutro Biopharma
STRO
$421M
$20.4M 1.1%
588,369
– –
BCYC
30
Bicycle Therapeutics
BCYC
$292M
$20.3M 1.1%
+1,010,976
New +$23.1M
ZURA icon
31
Zura Bio
ZURA
$566M
$18.8M 1.02%
2,850,000
– –
BSX icon
32
Boston Scientific
BSX
$71.5B
$18.7M 1.01%
353,741
+335,500
+1,839% +$17.6M
PROK icon
33
ProKidney
PROK
$337M
$17.7M 0.96%
3,867,843
+674,668
+21% +$6.46M
COF icon
34
Capital One
COF
$134B
$17.6M 0.95%
181,660
-16,910
-9% -$1.81M
WFC icon
35
Wells Fargo
WFC
$264B
$17.5M 0.95%
428,506
+5,000
+1% +$216K
APO icon
36
Apollo Global Management
APO
$73.4B
$17.2M 0.93%
+191,900
New +$16.1M
HLT icon
37
Hilton Worldwide
HLT
$71.5B
$17.1M 0.92%
113,962
-900
-0.8% -$136K
IFRX icon
38
InflaRx
IFRX
$271M
$17.1M 0.92%
5,733,910
– –
MCK icon
39
McKesson
MCK
$101B
$16.3M 0.88%
37,540
+35,710
+1,951% +$15M
JNJ icon
40
Johnson & Johnson
JNJ
$625B
$14M 0.76%
90,097
+7,297
+9% +$1.2M
UNH icon
41
UnitedHealth
UNH
$370B
$13.7M 0.74%
27,223
+14,400
+112% +$7.09M
SANA icon
42
Sana Biotechnology
SANA
$980M
$11.5M 0.62%
2,963,704
+849,904
+40% +$4.57M
AGIO icon
43
Agios Pharmaceuticals
AGIO
$1.93B
$11.2M 0.61%
454,000
– –
RCUS icon
44
Arcus Biosciences
RCUS
$3.64B
$10.7M 0.58%
+597,099
New +$12M
MREO
45
Mereo BioPharma
MREO
$47.3M
$9.5M 0.51%
7,364,438
– –
ANAB icon
46
AnaptysBio
ANAB
$1.68B
$8.61M 0.47%
+479,445
New +$9.15M
KZR
47
DELISTED
Kezar Life Sciences
KZR
$8.53M 0.46%
716,759
– –
ALVO icon
48
Alvotech
ALVO
$1.29B
$8.47M 0.46%
928,402
-71,598
-7% -$663K
SNY icon
49
Sanofi
SNY
$104B
$6.22M 0.34%
116,041
– –
ELAN icon
50
Elanco Animal Health
ELAN
$11.1B
$6.03M 0.33%
536,500
+99,600
+23% +$1.16M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Suvretta Capital Management held 109 positions worth $1.85B, down 1.1% from $1.87B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Suvretta Capital Management deployed $132M of net new capital in Q3 2023, opening 9 new positions and adding to 32 existing holdings. Its largest new stake was Microsoft: 218,170 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 61% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Oracle, an estimated $7.31M trimmed.

  • Suvretta Capital Management's largest Q3 2023 buy was Microsoft: 218,170 shares worth $68.9M.
  • Suvretta Capital Management added most to Amazon in Q3 2023, an estimated $39.1M increase.
  • Suvretta Capital Management's biggest Q3 2023 reduction was Oracle, cutting an estimated $7.31M.
  • Suvretta Capital Management fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $67.2M.
  • Suvretta Capital Management's ten largest holdings make up 47% of its $1.85B portfolio in Q3 2023.
  • Suvretta Capital Management opened 9 new positions and closed 22 in Q3 2023.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $1.85B.

Based on Suvretta Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.